SEC Form 4 research
| Issuer | Editas Medicine, Inc. |
|---|---|
| Tickers | EDIT |
| Reporting owners | 72 |
| Officers and directors | 19 |
| Last public filing | 2026-09-09 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-09 | 2026-09-08 | Ory Daniel Scott | A | 950,000 | $0 | Not reported |
| 2026-09-04 | 2026-09-03 | Parison Amy | S | 453 | $3.04 | Not reported |
| 2026-09-04 | 2026-09-03 | Burkly Linda | S | 709 | $3.04 | Not reported |
| 2026-09-04 | 2026-09-03 | O'Neill Gilmore Neil | S | 5,124 | $3.04 | Not reported |
| 2026-08-07 | 2026-08-06 | Ellinor Patrick Thomas II | A | 103,400 | $0 | Not reported |
| 2026-08-05 | 2026-08-03 | Parison Amy | S | 678 | $2.58 | Not reported |
| 2026-07-29 | 2026-07-28 | Burkly Linda | S | 4,928 | $2.67 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.